Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Endocrinologist
M.B.B.S., MSc., P.E.C
Gastroenterologist
M.B.B.S., F.C.P.S (Gastroenterology)
Internal Medicine Specialist
MBBS, MRCP (Medicine)
Cardiologist
M.B.B.S., F.C.P.S (Medicine), F.C.P.S (Cardiology)
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship Endocrinology and Diabetes
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, FRCP, MRCP, DTCD, DTM, DTH
Diabetologist
M.B.B.S., F.C.P.S (Endocrinologist), F.C.P.S (Medicine)
Internal Medicine Specialist
MBBS, M.D, Diplomat American Board of Internal Medicine
Internal Medicine Specialist
MBBS, M.D, Diplomat American Board of Internal Medicine
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures